Variation in the salivary peptide, maxadilan, from species in the Lutzomyia longipalpis complex

Maxadilan is an approximately 7kDa peptide that occurs in the saliva of the sand fly Lutzomyia longipalpis. This peptide is a potent vasodilator and may also have immunomodulatory effects related to the pathogenesis of leishmanial infections. Variation in the primary DNA and inferred amino acid sequ...

Full description

Saved in:
Bibliographic Details
Published inInsect molecular biology Vol. 8; no. 2; pp. 267 - 275
Main Authors Field, L. M., James, A. A., Lanzaro, G. C., Lopes, A. H. C. S., Ribeiro, J. M. C., Shoemaker, C. B., Warburg, A., Soares, M., Titus, R. G.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Science Ltd 01.05.1999
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Maxadilan is an approximately 7kDa peptide that occurs in the saliva of the sand fly Lutzomyia longipalpis. This peptide is a potent vasodilator and may also have immunomodulatory effects related to the pathogenesis of leishmanial infections. Variation in the primary DNA and inferred amino acid sequence of maxadilan is reported. Differences were found within and among natural field populations as well as among sibling species. Extensive amino acid sequence differentiation, up to 23%, was observed among maxadilan from different populations. This is a remarkable degree of polymorphism considering the small size of this peptide. The vasodilatory activity of maxadilan was equivalent among recombinant maxadilan variants. All maxadilan variants induce interleukin‐6. Predicted secondary structure and hydrophobicity plots suggest that these characteristics are conserved among variant peptides. However, profiles based on the antigenic index do differ among peptides.
Bibliography:ArticleID:IMBIMB82_0267
ark:/67375/WNG-6070WWN2-8
istex:B1E984C46F0139B29FE05403BE39077FA8794FB1
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0962-1075
1365-2583
DOI:10.1046/j.1365-2583.1999.820267.x